基本信息
浏览量:4
职业迁徙
个人简介
Area of Research
Raymond Reilly’s research focuses on developing novel radiopharmaceutical agents to detect and treat cancer. His work involves discovery, preclinical development and clinical translation of these agents for molecular imaging or molecularly targeted radiotherapy of cancer.
Research Challenge
Cancer is often challenging to treat, in part because each tumour is different. Tumours can vary in the genes that they express, the proteins that are displayed, and how they respond to treatments. To study a tumour’s molecular properties, oncologists are investigating an approach called molecular imaging, which can probe these tumour properties.
One approach to molecular imaging of cancer, used in nuclear medicine, involves a probe molecule tagged with a radioactive isotope that can be detected by imaging using either single-photon emission computed tomography (SPECT) or positron emission tomography (PET). To specifically image the properties of cancer cells, scientists can attach the radioactive isotope to a targeting agent that is capable of binding to the proteins displayed by the cancer cells. These compounds are called radiopharmaceuticals and can be used to detect and characterize the properties of tumours with very high sensitivity and specificity.
Raymond Reilly’s research focuses on developing novel radiopharmaceutical agents to detect and treat cancer. His work involves discovery, preclinical development and clinical translation of these agents for molecular imaging or molecularly targeted radiotherapy of cancer.
Research Challenge
Cancer is often challenging to treat, in part because each tumour is different. Tumours can vary in the genes that they express, the proteins that are displayed, and how they respond to treatments. To study a tumour’s molecular properties, oncologists are investigating an approach called molecular imaging, which can probe these tumour properties.
One approach to molecular imaging of cancer, used in nuclear medicine, involves a probe molecule tagged with a radioactive isotope that can be detected by imaging using either single-photon emission computed tomography (SPECT) or positron emission tomography (PET). To specifically image the properties of cancer cells, scientists can attach the radioactive isotope to a targeting agent that is capable of binding to the proteins displayed by the cancer cells. These compounds are called radiopharmaceuticals and can be used to detect and characterize the properties of tumours with very high sensitivity and specificity.
研究兴趣
论文共 305 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
EJNMMI radiopharmacy and chemistryno. 1 (2024): 42-42
iScienceno. 5 (2024): 109750
引用0浏览0引用
0
0
Cancer Researchno. 6_Supplement (2024): 6030-6030
EJNMMI Radiopharmacy and Chemistryno. 1 (2024): 1-47
iScienceno. 5 (2024): 109750-109750
Nuclear medicine and biology (2023): 108367-108367
引用0浏览0WOS引用
0
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn